All Type of News
Prof. Kang named multinational clinical test PI for Pfizer Sutent.Prof. Kang Yun-goo of Ulsan Univ. College of Medicine Oncology Department was appointed as the PI, a joint chief researcher of the multinational clinical studies for Sutent in t...
|
Assembly to screen suspicious prescription bill next weekThe National Assembly's Heath and Welfare Committee is scheduled to examine the bill to obligate doctors or dental doctors answer any suspicious contents of a prescription raise...
|
Sanofi's Actonel added indication for male osteoporosis.
Sanofi-Aventis Korea announced that the KFDA recently approved an additional indication of Actonel (risedronate sodium) for the treatment of male osteoporosis.
Actonel is a derivative of the bisphonphonates for the...
Ex-medical doctor named MSD's science ambassador
MSD Korea said on April 17 that the U.S.-based Merck Institute named Kim Kyu-chan, former Ex-medical doctor of Eulgi Hospital as a science of ambassador in Asia-Pacific region.
Kim, 57, will play a vital role in sc...
Foreign drug corporations to compete with local firms on rank.
The yearly sales between foreign multinational and local drug corporations seem to be hot competitive virtually this year.
The sales performances last year of local companies vs. foreigners showed a narrow gap, wh...
Jioyoung Group sales will hit 700 billion won this year
The domestic big three wholesalers have expanded market shares, as Jioyoung Group's sales of eight wholesalers posted 602.4 billion won last year.
Baije Pharm and Dongwon Pharm reported their sales breaking a 400-b...
Recalls on drug dwindle sharply
The number of pharmaceutical product recalls dramatically decreased last year as drug makers and importers are placing more weight on quality control for their products prior to marketing, according to a report re...
Medical institutions less using blood preparations.
The use volumes of blood preparations showed ever declining trends since 2002 when the government reviewed the propriety of blood transfusion therapy.
The HIRA reported after the review on the blood transfusion pro...
Exjade (deferasirox), breakthrough once-daily oral iron chelator, available in Korea
Exjade (deferasirox) is the first and only once-daily oral iron chelator for the treatment of iron overload in patients needing frequent blood transfusions for genetic blood disorders such as thalassaemia, sickle cell...
Multinational drug corporations to establish R&D centers in Korea
Many U. S. multinational drug corporations are going to make investments to Korea, exploiting great benefits from the recent KORUS FTA settlement between Korea and the United States.
KOTRA, a Korea trade promotion...
